Evidence map›Paper›PMID 31663669›Full record

ArticleMicrobial biotechnology2020

Preventive antibiotic treatment of calves: emergence of dysbiosis causing propagation of obese state-associated and mobile multidrug resistance-carrying bacteria.

Dorota A Dobrzanska, Matthew T F Lamaudière, Jessica Rollason, Lauren Acton, Michael Duncan, Sharon Compton, John Simms, Gareth D Weedall, Igor Y Morozov

Open access · goldAbstract read
In one paragraph

Article in Microbial biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 32 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Occurrence ofFrontiers in microbiology · 2022
    Article
  9. Article
  10. Review
  11. Review
  12. Properties of a New Probiotic Candidate and Lactobacterin-TKProbiotics and antimicrobial proteins · 2020
    Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Dorota A DobrzanskaCentre for Sport, Exercise and Life Sciences, Coventry University, Coventry, UK.
Matthew T F LamaudièreSchool of Life Sciences, Coventry University, Coventry, UK.
Jessica RollasonSchool of Life Sciences, Coventry University, Coventry, UK.
Lauren ActonSchool of Life Sciences, Coventry University, Coventry, UK.
Michael DuncanCentre for Sport, Exercise and Life Sciences, Coventry University, Coventry, UK.
Sharon ComptonMoreton Morrell College Farm, The Warwickshire College, Warwickshire, CV35 9BL, UK.
John SimmsSchool of Life Sciences, Coventry University, Coventry, UK.
Gareth D WeedallSchool of Natural Sciences and Psychology, Liverpool John Moores University, Liverpool, UK.
Igor Y MorozovCentre for Sport, Exercise and Life Sciences, Coventry University, Coventry, UK.ORCID 0000-0003-0927-0309
Coventry University · GBLiverpool John Moores University · GBWarwickshire College · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In agriculture, antibiotics are used for the treatment and prevention of livestock disease. Antibiotics perturb the bacterial gut composition but the extent of these changes and potential consequences for animal and human health is still debated. Six calves were housed in a controlled environment. Three animals received an injection of the antibiotic florfenicol (Nuflor), and three received no treatment. Faecal samples were collected at 0, 3 and 7 days, and bacterial communities were profiled to assess the impact of a therapy on the gut microbiota. Phylogenetic analysis (16S-rDNA) established that at day 7, antibiotic-treated microbiota showed a 10-fold increase in facultative anaerobic Escherichia spp, a signature of imbalanced microbiota, dysbiosis. The antibiotic resistome showed a high background of antibiotic resistance genes, which did not significantly change in response to florfenicol. However, the maintenance of Escherichia coli plasmid-encoded quinolone, oqxB and propagation of mcr-2, and colistin resistance genes were observed and confirmed by Sanger sequencing. The microbiota of treated animals was enriched with energy harvesting bacteria, common to obese microbial communities. We propose that antibiotic treatment of healthy animals leads to unbalanced, disease- and obese-related microbiota that promotes growth of E. coli carrying resistance genes on mobile elements, potentially increasing the risk of transmission of antibiotic resistant bacteria to humans.

Indexed as

BacteriaDysbiosisGastrointestinal MicrobiomeAnimalsAnti-Bacterial AgentsCattleDrug Resistance, BacterialEscherichia coliFemaleHumansObesityPhylogenyThiamphenicolAnti-Bacterial AgentsflorfenicolThiamphenicol

Identifiers

PMID31663669
PMCPMC7111097
OpenAlexW2982324827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.